Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
41
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Belite Bio Inc - ADR market cap is $6.62B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Belite Bio Inc - ADR 52 week high is $200.00 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Belite Bio Inc - ADR 52 week low is $105.88 as of November 15, 2026.
Belite Bio Inc - ADR stock price today is $164.36.
Belite Bio Inc - ADR stock price yesterday was $169.96.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Belite Bio Inc - ADR's P/E ratio is -58.06.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Belite Bio Inc - ADR P/B ratio is 8.6571.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Belite Bio Inc - ADR 50-day moving average is $160.88.
